Anthera Pharmaceuticals Inc Share Price Nasdaq
Equities
US03674U3005
Biotechnology & Medical Research
Sales 2016 | 0.14 12.1 | Sales 2017 | - | Capitalization | 22.85M 1.91B |
---|---|---|---|---|---|
Net income 2016 | -55M -4.59B | Net income 2017 | -26M -2.17B | EV / Sales 2016 | 4,40,69,434 x |
Net cash position 2016 | 20.84M 1.74B | Net cash position 2017 | 2.2M 183M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |